Gain the Greatest Insight from IND-Enabling Studies with CertisAI™ and Advanced Cancer Models

Time: 12:00 pm
day: Conference Day One


  • Accelerating drug discovery with in silico models that save time and money — predict therapeutic efficacy, disease indications, and model selection, identify biomarker signatures and more  
  • Ensuring clinical accuracy with advanced orthotopic PDX models that reliably mirror the behavior of cancer in their human counterparts 
  • Reducing variability between in vitro and in vivo studies by employing matched pairs of PDX models and 3D cell cultures derived from the same PDX models